Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AbbVie gets orphan drug and fast track status for elezanumab

pharmaceutical-technologyOctober 09, 2020

Tag: AbbVie , elezanumab , SCI

PharmaSources Customer Service